Researchers from Fred Hutchinson Cancer Research Center Detail Findings in Non-Hodgkin Lymphoma (Bortezomib and Vorinostat Therapy As Maintenance Therapy Post Autologous Transplant for Non-hodgkin's Lymphoma Using R-beam or Beam Transplant...).

At our center, this combination therapy post-transplant for Multiple Myeloma (MM) showed acceptable toxicity. Keywords for this news article include: Seattle, Washington, United States, North and Central America, Antineoplastics, Autologous Transplantation, Autologous Transplants, Biomedicine, Bortezomib Therapy, Cancer, Combination Therapy, Drugs and Therapies, Health and Medicine, Hematology, Histone Deacetylase Inhibitors, Immunoproliferative Disorders, Lymphatic Diseases and Conditions, Lymphoma, Lymphoproliferative Disorders, Non-Hodgkin Lymphoma, Oncology, Pharmaceuticals, Risk and Prevention, Surgery, Transplant Medicine, Vorinostat, Vorinostat Therapy, Fred Hutchinson Cancer Research Center. Keywords: Seattle; State:Washington; United States; North and Central America; Antineoplastics; Autologous Transplantation; Autologous Transplants; Biomedicine; Bortezomib Therapy; Cancer; Combination Therapy; Drugs and Therapies; Health and Medicine; Hematology; Histone Deacetylase Inhibitors; Immunoproliferative Disorders; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Non-Hodgkin Lymphoma; Oncology; Pharmaceuticals; Risk and Prevention; Surgery; Transplant Medicine; Vorinostat; Vorinostat Therapy EN Seattle State:Washington United States North and Central America Antineoplastics Autologous Transplantation Autologous Transplants Biomedicine Bortezomib Therapy Cancer Combination Therapy Drugs and Therapies Health and Medicine Hematology Histone Deacetylase Inhibitors Immunoproliferative Disorders Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Non-Hodgkin Lymphoma Oncology Pharmaceuticals Risk and Prevention Surgery Transplant Medicine Vorinostat Vorinostat Therapy 2703 2703 1 10/30/23 20231031 NES 231031 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Fresh data on Oncology - Non-Hodgkin Lymphoma are presented in a new report. [Extracted from the article]